Provided by Tiger Fintech (Singapore) Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

18.84
+0.15000.80%
Volume:60.39K
Turnover:1.13M
Market Cap:15.07M
PE:- -
High:18.85
Open:18.46
Low:18.43
Close:18.69
Loading ...

Company Profile

Company Name:
Virtus LifeSci Biotech Clinical Trials ETF
Exchange:
NASDAQ
Establishment Date:
2014
Employees:
- -
Office Location:
One Financial Plaza,Hartford,Connecticut,United States
Website:
- -
Zip Code:
06103
Fax:
(860) 241-1024
Introduction:
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.